Free Trial
LON:FUM

Futura Medical 4/15/2025 Earnings Report

Futura Medical logo
GBX 12.50 +0.25 (+2.04%)
As of 08/1/2025 11:50 AM Eastern

Futura Medical EPS Results

Actual EPS
GBX 0.43
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Futura Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Futura Medical Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Futura Medical Earnings Headlines

Market Crash Warning: How to Protect Your Wealth Before August 12th
China tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alternative Assets reveals 3 urgent moves to protect your portfolio, plus the #1 asset class thriving during crises (hint: it’s not stocks or bonds).
Futura Stock Price History - Investing.com
See More Futura Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Futura Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Futura Medical and other key companies, straight to your email.

About Futura Medical

Futura Medical (LON:FUM), a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

View Futura Medical Profile

More Earnings Resources from MarketBeat